Correlation Between Affimed NV and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Elevation Oncology, you can compare the effects of market volatilities on Affimed NV and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Elevation Oncology.
Diversification Opportunities for Affimed NV and Elevation Oncology
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Affimed and Elevation is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Affimed NV i.e., Affimed NV and Elevation Oncology go up and down completely randomly.
Pair Corralation between Affimed NV and Elevation Oncology
Given the investment horizon of 90 days Affimed NV is expected to under-perform the Elevation Oncology. In addition to that, Affimed NV is 1.05 times more volatile than Elevation Oncology. It trades about -0.08 of its total potential returns per unit of risk. Elevation Oncology is currently generating about 0.13 per unit of volatility. If you would invest 57.00 in Elevation Oncology on September 1, 2024 and sell it today you would earn a total of 7.00 from holding Elevation Oncology or generate 12.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Affimed NV vs. Elevation Oncology
Performance |
| Timeline |
| Affimed NV |
| Elevation Oncology |
Affimed NV and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Affimed NV and Elevation Oncology
The main advantage of trading using opposite Affimed NV and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Affimed NV vs. Tff Pharmaceuticals | Affimed NV vs. Eliem Therapeutics | Affimed NV vs. Inhibrx | Affimed NV vs. Enliven Therapeutics |
| Elevation Oncology vs. Tff Pharmaceuticals | Elevation Oncology vs. Eliem Therapeutics | Elevation Oncology vs. Inhibrx | Elevation Oncology vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |